Structure Therapeutics Inc - American Depositary Shares — 財務諸表 (NASDAQ:GPCR) | MetaTrader

チャート全体を表示

ニュース

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO、肥満治療薬データを受けStructure Therapeuticsの目標株価を引き上げ

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)

H.C. Wainwrightがストラクチャー・セラピューティクスの目標株価を引き下げ、浸透率の前提を見直し

H.C. Wainwright lowers Structure Therapeutics price target on penetration assumptions

シチズンズ、減量データを受けストラクチャー・セラピューティクス株の投資判断を維持